Stay updated on Nivolumab Ipilimumab in Mucinous Tumors Clinical Trial

Sign up to get notified when there's something new on the Nivolumab Ipilimumab in Mucinous Tumors Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab Ipilimumab in Mucinous Tumors Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    Revision: v3.4.3 is now shown on the page, replacing v3.4.2.
    Difference
    0.1%
    Check dated 2026-03-11T17:39:57.000Z thumbnail image
  2. Check
    13 days ago
    No Change Detected
  3. Check
    20 days ago
    No Change Detected
  4. Check
    34 days ago
    Change Detected
    Summary
    Addition of Revision: v3.4.2 and deletion of government funding/outage notices (Revision: v3.4.1); these are site-wide maintenance updates and do not alter trial-specific content.
    Difference
    0.4%
    Check dated 2026-02-11T05:26:35.000Z thumbnail image
  5. Check
    41 days ago
    Change Detected
    Summary
    Site-wide government funding notice was added and the page revision tag updated from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.5%
    Check dated 2026-02-04T04:52:24.000Z thumbnail image
  6. Check
    48 days ago
    Change Detected
    Summary
    Minor UI/metadata updates were implemented, such as Show glossary and revision/version label changes (v3.4.0; No FEAR Act Data; Last Update Submitted that Met QC Criteria), with core study content unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2026-01-28T03:10:17.000Z thumbnail image
  7. Check
    62 days ago
    Change Detected
    Summary
    The page now displays a new revision note 'Revision: v3.3.4' and the previous 'Revision: v3.3.3' note was removed.
    Difference
    0.1%
    Check dated 2026-01-14T03:02:11.000Z thumbnail image
  8. Check
    84 days ago
    Change Detected
    Summary
    A new 'Locations' section is added with Pennsylvania listed as a site. The page footer shows revision v3.3.3, and the earlier 'Pennsylvania Locations' entry and 'HHS Vulnerability Disclosure' have been removed.
    Difference
    0.2%
    Check dated 2025-12-23T17:17:19.000Z thumbnail image

Stay in the know with updates to Nivolumab Ipilimumab in Mucinous Tumors Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab Ipilimumab in Mucinous Tumors Clinical Trial page.